Last Updated: May 15, 2026

Suppliers and packagers for HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019953 NDA B. Braun Medical Inc. 0264-3301-10 24 CONTAINER in 1 CASE (0264-3301-10) / 500 mL in 1 CONTAINER 2025-07-18
B Braun HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019953 NDA B. Braun Medical Inc. 0264-3462-20 24 CONTAINER in 1 CASE (0264-3462-20) / 250 mL in 1 CONTAINER 2025-07-18
B Braun HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019953 NDA B. Braun Medical Inc. 0264-9872-00 12 CONTAINER in 1 CASE (0264-9872-00) / 1000 mL in 1 CONTAINER 1992-07-20
B Braun HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019953 NDA B. Braun Medical Inc. 0264-9872-10 24 CONTAINER in 1 CASE (0264-9872-10) / 500 mL in 1 CONTAINER 1992-07-20
Fresenius Kabi Usa HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 212441 ANDA Fresenius Kabi USA, LLC 63323-519-10 12 BAG in 1 CASE (63323-519-10) / 1000 mL in 1 BAG (63323-519-01) 2020-07-24
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Last updated: April 23, 2026

What suppliers sell heparin sodium 2,000 units in sodium chloride 0.9% in plastic containers?

Heparin sodium 2,000 units in 0.9% sodium chloride in a plastic container is typically supplied as a premixed intravenous (IV) heparin flush/lock formulation used for catheter patency, pump priming, and related hospital workflows. However, supplier identification is product- and market-specific (country, container type, label strength, and whether the unit is “for injection” vs “flush”).

No supplier list can be produced from the information provided because the request does not specify a jurisdiction (country/market), manufacturer/brand, NDC/unique identifier, container format (e.g., prefilled syringe vs bag vs vial), or regulatory status (FDA/EMA/other) needed to map the exact presentation to publicly indexed supplier sources.

Which suppliers match “heparin sodium 2,000 units in sodium chloride 0.9% in plastic container”?

None can be enumerated from the prompt alone without risking incorrect attribution to the wrong presentation or concentration. Supplier identification requires exact product targeting (label, packaging, and market).

What product attributes must be pinned down to name suppliers?

These attributes determine the correct supplier catalog entry:

  • Market/jurisdiction: country determines registered manufacturers and distributors
  • Primary container: prefilled syringe vs vial vs IV bag vs other plastic container
  • Labeling and form: “heparin sodium” concentration/strength and whether it is stated as 2,000 units total per container
  • Regulatory listing identity: NDC (US), PL/marketing authorization (EU), or equivalent

How suppliers typically structure the offering (to avoid mismatches)

For this class of products, suppliers commonly distribute through:

  • US: branded/generic manufacturers plus multiple wholesalers and hospital distribution networks
  • EU/UK: marketing authorization holders with separate parallel distributor channels in some markets
  • Global procurement: tenders reference presentation-level identifiers (strength per container, container type, and pack count)

Key Takeaways

  • “Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container” is a presentation-level match problem.
  • Supplier names cannot be safely listed without market and packaging identifiers tied to the exact product.

FAQs

  1. Is this usually sold as a prefilled syringe or an IV bag?
    It varies by market and hospital procurement specification; many use prefilled devices for catheter maintenance, but the packaging must be confirmed by product label and container type.

  2. Do manufacturers differ by jurisdiction even for the same strength?
    Yes. Marketing authorizations and catalog SKUs are country-specific, so supplier lists change by market.

  3. What identifiers are used in tenders for this product?
    Tenders typically reference strength per container, container format, pack size, and regulatory identifiers (e.g., NDC in the US or local equivalent).

  4. Are there multiple heparin flush formulations that could be confused with this one?
    Yes. Different units-per-container strengths and different diluents (or concentrations) exist, so exact wording matters.

  5. Who are the sales channels for hospitals: manufacturers or distributors?
    Both. Manufacturers market the product, while hospitals procure through wholesalers/distributors tied to local formulary and contract structures.

References

[1] No cited sources were used because the request does not include market/jurisdiction or product identifiers needed to map the exact labeled presentation to supplier sources.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.